Major Objectives of this Study:
# To define, describe, and forecast the Global Protein Binding Assay Industry
on the basis of technology, end user, and regions.
# To provide detailed information about factors influencing
market growth (drivers, restraints, opportunities, and industry-specific
challenges).
# To strategically analyze the micromarkets with respect to
individual growth trends, prospects, and contributions to the overall market.
# To analyze market opportunities for stakeholders and
provide details of the competitive landscape for key players.
# To forecast the size of the market segments with respect
to four major regional segments, namely, North America, Europe, Asia Pacific,
and the Rest of the World (RoW).
# To profile the key players in the market and
comprehensively analyze their market positions and core competencies.
# To track and analyze competitive developments such as
partnerships, agreements, and joint ventures; mergers and acquisitions; product
development; and research and development activities in the protein binding
assay market
Factors
Influencing Global Industry Growth:-
The increasing use of protein binding assays in pre-clinical
research for studying the distribution properties of the drug, and the growing
number of drug discovery activities, the minimizing drug discovery and
development costs, and the increase in pharmaceutical R&D expenditure is
driving the growth of this market.
Restraints:
# Issues with Existing Technologies
Opportunities:
# Growing CRO Industry
Challenges:
# Development of in Silico-Based Prediction
Models
Looking Out for
More Details | Don’t Hesitate to Download the PDF
Brochure@
Industry’s
Revenue Growth Expectations:
The global protein binding assays market is
projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at
CAGR of 10.7%.
Geographical Growth Scenario:
Asia Pacific is expected to grow at the highest CAGR during
the forecast period
The APAC market is projected to register the highest growth
rate during the forecast period primarily due to factors such as, growth of
clinical trial activities in several APAC countries. As a result of this, the
pharmaceutical and biopharmaceutical companies are outsourcing their drug
discovery and development activities to APAC-based CROs. This is one of the
major factors driving the growth of the protein binding assay market in the
Asia Pacific.
Target
Audience:
# Government and academic institutes
# Protein binding assay providers
# R&D departments
# Contract research organizations
# Pharmaceutical & biotechnology companies
# Consulting firms
# Government associations
Leading Market
Players:
#
HTDialysis (US)
# Thermo Fisher Scientific (US)
# Merck (Germany)
# Sovicell (Germany) and many more…
Most companies focus on agreements, collaborations, and
partnerships to compete in the market. The players also focus on increasing
their presence in high-growth markets through acquisitions and product
launches.
Thermo Fisher (US), Sovicell (Germany) and 3B Pharmaceutical focus on
partnerships, collaboration and license agreements to strengthen their position
in the market.
Read More:
In 2017, Thermo Fisher was the leading player in the protein
binding assay market. The company has a strong geographic presence across the
US, Europe, Greater China, and Asia Pacific. The company focuses on a wide
range of products offering in the protein binding assay market.
The
company’s products are based on the equilibrium dialysis technology, which
helps it dominate this market. The company focuses on partnerships to enhance
its presence in the market. In 2018, Thermo Fisher partnered with The Montreal
Neurological Institute (The Neuro) of the McGill University (Canada) to provide
reagents and tools to understand neurological diseases.
No comments:
Post a Comment